Instrumento Inactivo

Otros idiomas Northwest Biotherapeutics, Inc OTC Bulletin Board

Acciones

US66737P5017

Precio de cierre OTC Bulletin Board Otros sitios de cotización
- ^USD	-

10/05	Northwest Biotherapeutics, Inc. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
21/03	Northwest Biotherapeutics, Inc. nombra a Pat Sarma miembro de su Consejo de Administración	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property	17/06
Northwest Biotherapeutics: Q1 Earnings Snapshot	10/05
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	21/03
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	14/03
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification	06/02
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma	22/12
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma	21/12
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma	21/12
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application	22/11
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC	10/11
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)	19/10/23
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application	16/10/23
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application	13/10/23
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE	28/09/23
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)	25/09/23
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)	14/09/23
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)	13/09/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Northwest Biotherapeutics, Inc OTC Bulletin Board

Acciones

US66737P5017

Otros idiomas

Filtros